Related references
Note: Only part of the references are listed.SURG-03. LAYER-BY-LAYER CORE-SHELL NANOPARTICLES FOR THE DELIVERY OF HDAC INHIBITORS TO THE CENTRAL NERVOUS SYSTEM
Michael H Marand et al.
NEURO-ONCOLOGY (2023)
Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency
Anirban Das et al.
NATURE MEDICINE (2022)
Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies
Izac J. Findlay et al.
ONCOGENE (2022)
Focused Ultrasound-Mediated Blood-Brain Barrier Opening Enhances Panobinostat Efficacy in a Murine Diffuse Intrinsic Pontine Glioma Model
H.J. Wei et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis
Nicholas A. Vitanza et al.
NATURE MEDICINE (2021)
Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naive diffuse midline glioma models
Nicholas A. Vitanza et al.
NEURO-ONCOLOGY (2021)
Pediatric high-grade glioma resources from the Children's Brain Tumor Tissue Consortium
Heba Ijaz et al.
NEURO-ONCOLOGY (2020)
Massively multiplex chemical transcriptomics at single-cell resolution
Sanjay R. Srivatsan et al.
SCIENCE (2020)
HDAC inhibitors overcome immunotherapy resistance in B-cell lymphoma
Xiaoguang Wang et al.
PROTEIN & CELL (2020)
Mechanisms and therapeutic implications of hypermutation in gliomas
Mehdi Touat et al.
NATURE (2020)
Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience
Erin E. Crotty et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
A simple and highly efficient method for multi-allelicCRISPR-Cas9editing in primary cell cultures
Pia Hoellerbauer et al.
CANCER REPORTS (2020)
Diffuse Intrinsic Pontine Glioma: From Diagnosis to Next-Generation Clinical Trials
Nicholas A. Vitanza et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2019)
Epigenetic Drugs for Cancer and microRNAs: A Focus on Histone Deacetylase Inhibitors
Pierre Autin et al.
CANCERS (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
Lynch syndrome associated ultra-hypermutated pediatric glioblastoma mimicking a constitutional mismatch repair deficiency syndrome
Chen Yang et al.
COLD SPRING HARBOR MOLECULAR CASE STUDIES (2019)
Histone deacetylase inhibition up-regulates MHC class I to facilitate cytotoxic T lymphocyte-mediated tumor cell killing in glioma cells
Ting Sun et al.
JOURNAL OF CANCER (2019)
pH driven precipitation of quisinostat onto PLA-PEG nanoparticles enables treatment of intracranial glioblastoma
Kyle T. Householder et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2018)
Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial
Mark M. Souweidane et al.
LANCET ONCOLOGY (2018)
The landscape of genomic alterations across childhood cancers
Susanne N. Groebner et al.
NATURE (2018)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2018)
Durable Response to Nivolumab in a Pediatric Patient with Refractory Glioblastoma and Constitutional Biallelic Mismatch Repair Deficiency
Musa AlHarbi et al.
ONCOLOGIST (2018)
Sustained complete response of recurrent glioblastoma to combined checkpoint inhibition in a young patient with constitutional mismatch repair deficiency
Valerie Larouche et al.
PEDIATRIC BLOOD & CANCER (2018)
Constitutional mismatch repair-deficiency: current problems and emerging therapeutic strategies
Malak Abedalthagafi
Oncotarget (2018)
Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets
Tessa B. Johung et al.
CURRENT NEUROPHARMACOLOGY (2017)
Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study
Tabitha Cooney et al.
NEURO-ONCOLOGY (2017)
Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures
Adrienne Johnson et al.
ONCOLOGIST (2017)
Integrating RNA sequencing into neuro-oncology practice
David S. Rogawski et al.
TRANSLATIONAL RESEARCH (2017)
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
Alan Mackay et al.
CANCER CELL (2017)
Transcriptional Dependencies in Diffuse Intrinsic Pontine Glioma
Surya Nagaraja et al.
CANCER CELL (2017)
High frequency of mismatch repair deficiency among pediatric high grade gliomas in Jordan
Nisreen Amayiri et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
Eric Bouffet et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Histone deacetylase inhibitors as immunomodulators in cancer therapeutics
Li Shen et al.
EPIGENOMICS (2016)
Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers
Adam Shlien et al.
NATURE GENETICS (2015)
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
Catherine S. Grasso et al.
NATURE MEDICINE (2015)
The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma
Gang Wu et al.
NATURE GENETICS (2014)
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
Kathryn R. Taylor et al.
NATURE GENETICS (2014)
Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma
Chris Jones et al.
NATURE REVIEWS CANCER (2014)
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
Dong-Anh Khuong-Quang et al.
ACTA NEUROPATHOLOGICA (2012)
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Jeremy Schwartzentruber et al.
NATURE (2012)
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
Gang Wu et al.
NATURE GENETICS (2012)
Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group
Kenneth J. Cohen et al.
NEURO-ONCOLOGY (2011)
Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment
Daniel P. Cahill et al.
CLINICAL CANCER RESEARCH (2007)
A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy
C Hunter et al.
CANCER RESEARCH (2006)
Histone acetylation-independent effect of histone deacetylase inhibitors on Akt through the reshuffling of protein phosphatase 1 complexes
CS Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Share Paper
